HBAN HUNTINGTON BANCSHARES INC /MD/ Insider Trading

Director James D Iii Rollins sold 223.5K HBAN shares at $17.35 for $3.9M, reducing holdings by -26.7%

Rollins sold 223,522 shares at $17.35 on 2026-06-12, the largest reduction in his HBAN holdings (-26.7% vs pre-transaction level), leaving him with 612,155 shares. This sale occurred just days after he executed four buy transactions at the same ticker (2026-06-02 through 2026-06-04), creating a contradictory trading sequence. His cross-ticker track record shows 14 prior buys with a 90-day win rate of 0.00% and average 90-day returns of -24.6%, while his sole measurable prior buy at HBAN (2026-04-28) declined -23.4% over 30 days. The current stock price of $17.32 sits -11.0% from the 52-week high of $19.46, despite recent 30-day and 90-day price appreciation of +12.4% and +14.6% respectively. The company's fundamentals remain solid with a P/E of 15.89 and annual revenue growth of +6.4%.

Director Rollins buys 22,000 shares of HBAN in 4 transactions totaling $401.2K at $18.24 blended average

James D Iii Rollins, a director of Huntington Bancshares, executed 4 separate purchases totaling 22,000 shares for $401.2K between June 2-4, 2026, at prices ranging from $16.46 to $20.35. His post-transaction holdings stand at 10,000 shares. However, his track record raises concerns about timing discipline: across his 5 prior trades at HBAN, his 90-day win rate is 0% (0 of 5 buys were followed by positive 90-day returns), with prior purchases suffering losses ranging from -6.2% to -37.3%. His cross-ticker track record similarly shows an average 90-day return of -23.6% across 10 buys, with a 0.00% win rate. The current price of $16.53 is -15.1% from the 52-week high and below his blended purchase price of $18.24, suggesting immediate mark-to-market underwater position. This purchase pattern, combined with the consistent historical underperformance of his prior HBAN acquisitions, merits observation but does not constitute a strong vote of confidence given the execution outcomes.

Director James D Rollins III purchases 11,500 shares of HBAN across three transactions, signaling confidence in fundamentally sound bank.

James D Rollins III, a board director with operational visibility into HBAN, made a substantial three-part open-market purchase totaling approximately 11,500 shares over two trading days. This comes while the stock trades noticeably below its recent highs, creating a technical setup where insider buying often signals confidence—Rollins is buying a pullback rather than chasing momentum. Huntington Bancshares is a profitable, revenue-growing bank trading at a reasonable valuation multiple, making it the type of fundamentally sound business that typically attracts insider accumulation. The clustering of purchases across consecutive days, rather than a single block trade, suggests deliberate accumulation by someone with board-level knowledge of the company's trajectory. While individual director purchases are routine, the scale and timing of this accumulation during a period of price weakness deserves attention from investors seeking to identify informed conviction among management.

Senior EVP Scott D Kleinman sells 65,530 HBAN shares at $15.28; stock down -20.7% from 52-week high.

Scott D Kleinman, Senior Executive Vice President, sold 65,530 shares of Huntington Bancshares at $15.28 on 2026-03-12, reducing his holdings from 547.2K to 481.7K shares. The sale occurred as HBAN trades -20.7% below its 52-week high of $19.27 and -11.5% over the prior 30 days. Notably, Kleinman's prior HBAN sale on 2025-03-13 occurred after which the stock returned +9.7% over 90 days—a poorly-timed outcome. His cross-ticker track record across all securities shows 1 prior sell with a 90-day well-timed rate of 0.00%, indicating no pattern of prescient exit timing. The sale occurs amid the stock's recent weakness, though the company's fundamentals show net income of $629.0M against quarterly revenue of $424.0M and a P/E of 12.42.

HBAN CEO Steinour buys 32,277 shares at $15.49; stock now $15.28 vs $19.27 52-week high.

CEO Stephen D Steinour purchased 32,277 shares of Huntington Bancshares at $15.49 on March 12, 2026, adding to a 1.44M share post-transaction position. The purchase occurred after a significant pullback: the stock is -20.7% from its 52-week high of $19.27 and down -11.5% over 30 days. Huntington's fundamentals remain solid with a P/E of 12.42 and annual revenue growth of +6.4%, supporting a $31.0B market cap. Steinour's prior open-market purchase across all tickers generated a 100.00% 90-day win rate with +13.8% average return, establishing a track record of favorable outcome timing. This buy by the top executive at depressed valuation relative to recent trading range represents material accumulation in his own company during a period of stock weakness.

Director Rollins buys 4,915 shares of HBAN at $17.65; stock now at $16.83, -12.7% from 52-week high

James D III Rollins, a Director, purchased 4,915 shares at $17.65 on 2026-03-03, establishing an initial position of 4,915 shares with a transaction value of $86,749.75. The purchase occurs within a period of intensifying buying activity: Rollins completed three separate purchases of HBAN stock on 2026-02-27 (two transactions) and 2026-03-02, indicating a deliberate accumulation pattern over consecutive trading days. The timing context is notable—the current price of $16.83 reflects a -12.7% decline from the 52-week high of $19.27 and a -5.9% decline over the past 30 days, suggesting the director was acquiring shares during a period of price weakness relative to recent peaks. HBAN fundamentals remain solid with annual revenue growth of 6.4%, a P/E of 13.68, and quarterly net income of $629,000,000, though the recent price action indicates near-term market headwinds or sector pressure.

Director James D Rollins III bought 7,373 shares for $170,616.74 across 3 transactions; stock now down 13.1% from 52-week high.

Director James D Rollins III executed 3 separate purchases totaling 7,373 shares for $170,616.74 at blended average price of $23.14 across February and March 2026. The current price of $16.75 sits 13.1% below the 52-week high of $19.27, indicating the stock has declined materially since his purchases. His post-transaction holdings stand at 4,500 shares. While the company shows solid fundamentals with $424.0M quarterly revenue, $629.0M net income, and a reasonable P/E of 13.62, the director's purchases occurred at meaningfully higher valuations than current levels, and his prior cross-ticker history shows only 1 prior buy with no established pattern. The timing of these purchases relative to the subsequent price weakness merits observation, though limited historical context at this ticker constrains broader pattern assessment.

Director Torgow buys 14,200 HBAN shares at $17.81; holdings reach 943.3K shares.

Gary Torgow, a director of Huntington Bancshares, purchased 14,200 shares for $252,902.00, increasing his holdings to 943.3K shares. The buy occurs near the 52-week high of $19.27, with the stock currently trading at $17.08, representing a -11.4% retracement from peak levels. His prior buy at this ticker in May 2023 produced a +4.3% 90-day return, establishing a pattern of open-market acquisitions at Huntington. The company's fundamentals show solid positioning with $424.0M in revenue last quarter, $629.0M net income, and a moderate P/E of 13.89, suggesting the security is not trading at distressed levels. The transaction is discretionary and occurs at a price point above the current market level, reflecting a purchase decision made in mid-February before the recent pullback.

Director John C Inglis bought 6,506 shares of HBAN at $15.30 on 2025-11-04, raising holdings to 89,831 shares

Director John C Inglis purchased 6,506 shares at $15.30, a price 0.06% below the current market price of $15.29, yet 16.0% below the 52-week high of $18.20. His holdings increased 7.8% to 89,831 shares following the transaction. However, his cross-ticker track record shows limited predictive power: 10 prior open-market buys averaged only -0.5% return over 30 days and -0.1% over 90 days, with a 90-day win rate of just 37.50%. The stock itself has declined 8.5% over the past 30 days and 3.6% over 90 days, placing the timing of this purchase within a period of downward momentum. Fundamental metrics are modest—the company trades at a P/E of 10.06 with net income of $629.0M against a market cap of $22.3B—but insufficient context exists to determine whether this represents conviction or routine portfolio management at a lower price level.

HBAN General Counsel Hingst sells 41,100 shares at $18.00; retains 299,361 shares post-transaction

Marcy C Hingst, Senior Executive Vice President and General Counsel of Huntington Bancshares, sold 41,100 shares at $18.00 on 2025-09-05, representing a 12.1% reduction in her reported holdings. The sale occurred near the 52-week high of $18.20 and the stock has since declined to $17.64. Hingst retains significant holdings of 299,361 shares, indicating continued material ownership in the company. The transaction appears to be a discrete, isolated disposition rather than a pattern within a broader holdings strategy, though the volume and context relative to her remaining stake merit observation by stakeholders monitoring executive equity commitment.